Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000484947 | SCV000192080 | likely benign | not specified | 2016-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001088171 | SCV000551639 | benign | Developmental and epileptic encephalopathy, 1; Intellectual disability, X-linked, with or without seizures, arx-related | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000145042 | SCV000566602 | likely benign | not provided | 2020-09-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000623262 | SCV000850637 | benign | Inborn genetic diseases | 2018-06-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000145042 | SCV000202189 | uncertain significance | not provided | 2014-02-06 | no assertion criteria provided | clinical testing | |
Diagnostic Laboratory, |
RCV000145042 | SCV001742699 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000145042 | SCV001797514 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000145042 | SCV001971970 | likely benign | not provided | no assertion criteria provided | clinical testing |